FindTrial
Sign In

Outcome of Ygyatherapy(adjuvant) in newly diagnosed pulmonary TB patient

Outcome of Ygyatherapy(adjuvant) in newly diagnosed pulmonary TB patient-Non randomized control trial study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056005
Enrollment
20
Registered
2023-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Yagya therapy as adjuvant therapy in pulmonary TB patients: exposure group will be exposed to yagyatherapy for 1month and on follow up on next month they will be compare with non expo

Sponsors

otorhinolaryngology department
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: adult newly diagnosed pulmonary tuberculosis patients

Exclusion criteria

Exclusion criteria: Patients who are PLHA positive along with TB Patients with MDR and XDR TB Pregnant and lactating woman Patients with asthma and COPD Patients with history of allergy

Design outcomes

Primary

MeasureTime frame
weight gain, Sputum smear status, chest x-ray finding improvementTimepoint: At end of 1st and 2nd month of therapy—

Secondary

MeasureTime frame
To assess changes in X-ray chest in adult TB patient on AKT with add on yagyatherapy at 1st and 2nd month of therapy To assess AFB smear in adult TB patient on AKT with add on yagyatherapy at 1st and 2nd month of therapy Timepoint: At end of 1st and 2nd month of therapy—

Countries

India

Contacts

Public ContactDr Sushilkumar G Jha

Goverment Medical Collage Bhavnagar

sushilkgjhatanmay@gmail.com09426909700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026